Endofotonics
Updated: February 06, 2026
Founders: Ms Florence Leong, Huang Zhiwei, Lawrence Ho
Country: Singapore | Funding: $9.1M (+)
Founded: 2013
Website: http://www.endofotonics.com/
Endofotonics has developed SPECTRA IMDx - AI-based system, which enables real-time detection of early-stage gastric cancer during endoscopy. According to the company, it is the world's first and only in-vivo molecular diagnostic system using Raman spectroscopy for the early detection of gastric cancer. It acquires and analyzes molecular information related to cellular metabolic components when tissue molecules are excited by light energy directed at the tissue. The AI model is trained on clinical data to distinguish the molecular signatures of high-risk gastric lesions. The miniature SPECTRA IMDx probe is compatible with existing gastrointestinal endoscopes. The system provides objective feedback in real time, allowing the physician to focus attention and better analyze visual features.
Founded: 2013
Website: http://www.endofotonics.com/
Endofotonics has developed SPECTRA IMDx - AI-based system, which enables real-time detection of early-stage gastric cancer during endoscopy. According to the company, it is the world's first and only in-vivo molecular diagnostic system using Raman spectroscopy for the early detection of gastric cancer. It acquires and analyzes molecular information related to cellular metabolic components when tissue molecules are excited by light energy directed at the tissue. The AI model is trained on clinical data to distinguish the molecular signatures of high-risk gastric lesions. The miniature SPECTRA IMDx probe is compatible with existing gastrointestinal endoscopes. The system provides objective feedback in real time, allowing the physician to focus attention and better analyze visual features.
